COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Jilin Zixin Pharmaceutical Co., Ltd. Announcement on the Dissolution of Shareholder Equity and Re-Pledge
Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-003
Jilin Zixin Pharmaceutical Co., Ltd.
Announcement on the dissolution of shareholder pledge and re-pledge
On January 18, 2013, the company received the controlling shareholder Dunhua Kangping Investment Co., Ltd. (hereinafter referred to as Kangping Company) Notice: Kangping Company pledges to Jilin Bank Co., Ltd. Changchun Ruixiang Sub-branch on January 18, 2012 (hereinafter referred to as : Ruixiang Branch) The company's unrestricted tradable shares of 53,480,000 shares (accounting for 10.43% of the company's total share capital, accounting for 21.27% of the company's shares held by the company) on January 17, 2013 at China Securities Depository and Clearing Co., Ltd. Shenzhen The branch handled the pledge registration formalities. On the same day, Kangping Company re-plied the above shares to Ruixiang Sub-branch and went through the pledge registration formalities at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. The pledge period began on January 17, 2013 and the pledgee handled the pledge registration. The day of the procedure.
As of the date of this announcement, Kangping Company has pledgeed 250,680,000 shares of the Company (accounting for 99.68% of the shares held by Kangping Company), accounting for 48.87% of the company's total share capital.
Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors
January 19, 2013